Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Goodin

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
International MS Journal|January 19, 2006
Treatment of multiple sclerosis with human beta interferonD S Goodin
Neuroepidemiology|February 19, 1999
Perils and pitfalls in the interpretation of clinical trials: a reflection on the recent experience in multiple sclerosisD S Goodin
Drugs|November 6, 2001
Interferon-beta therapy in multiple sclerosis: evidence for a clinically relevant dose responseD S Goodin
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|March 21, 1998
Cognitive event-related potentialsD S Goodin
Handbook of Clinical Neurology|September 18, 2016
The epidemiology of multiple sclerosis: insights to a causal cascadeD S Goodin
Neurology|March 1, 1993
Corticosteroids and optic neuritisD S Goodin
Neurology|December 1, 1993
Treatment of optic neuritisD S Goodin
Lancet (London, England)|February 16, 1999
Interferon beta treatment for multiple sclerosisD S Goodin
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 10, 2009
Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episodeD S Goodin, D Bates
Muscle & Nerve. Supplement|January 3, 2001
Studies of the human stretch reflexM J Aminoff, D S Goodin
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
International MS Journal|January 19, 2006
Treatment of multiple sclerosis with human beta interferonD S Goodin
Neuroepidemiology|February 19, 1999
Perils and pitfalls in the interpretation of clinical trials: a reflection on the recent experience in multiple sclerosisD S Goodin
Drugs|November 6, 2001
Interferon-beta therapy in multiple sclerosis: evidence for a clinically relevant dose responseD S Goodin
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|March 21, 1998
Cognitive event-related potentialsD S Goodin
Handbook of Clinical Neurology|September 18, 2016
The epidemiology of multiple sclerosis: insights to a causal cascadeD S Goodin
Neurology|March 1, 1993
Corticosteroids and optic neuritisD S Goodin
Neurology|December 1, 1993
Treatment of optic neuritisD S Goodin
Lancet (London, England)|February 16, 1999
Interferon beta treatment for multiple sclerosisD S Goodin
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 10, 2009
Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episodeD S Goodin, D Bates
Muscle & Nerve. Supplement|January 3, 2001
Studies of the human stretch reflexM J Aminoff, D S Goodin
Pageof 11